All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Study Links Glucosamine Supplement to Faster Cognitive Decline in People With Mild Cognitive Impairment

By

Megan Brooks

22h ago· 5 min readenNews

Summary

A new study analyzing electronic health records found that glucosamine, a popular joint supplement, was associated with a 25% higher likelihood of progression from mild cognitive impairment (MCI) to dementia over 5 years. Experiments in human brain tissue and mouse models suggest that excessive protein glycosylation may contribute to Alzheimer's disease progression, and glucosamine supplementation could exacerbate this process. The research identifies glycan metabolism as a potential new therapeutic target for Alzheimer's disease.

Source

Twitter / XStudy Links Glucosamine Supplement to Faster Cognitive Decline in People With Mild Cognitive Impairmentmdsc.pe

Key quotes

· 3 pulled
Glucosamine use was associated with a 25% higher likelihood of progression from MCI to dementia over 5 years.
Experiments in human brain tissue and mouse models suggested that excessive protein glycosylation may contribute to Alzheimer's disease progression.
Glucosamine supplementation could exacerbate the progression of Alzheimer's disease through excessive protein glycosylation.
Snippet from the RSS feed
A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.

You might also wanna read